The store will not work correctly when cookies are disabled.
(RR/SS)-2-[1-(3,4-dichlorophenyl)butyl]piperidine
ID: ALA219649
PubChem CID: 16102764
Max Phase: Preclinical
Molecular Formula: C15H21Cl2N
Molecular Weight: 286.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCC(c1ccc(Cl)c(Cl)c1)C1CCCCN1
Standard InChI: InChI=1S/C15H21Cl2N/c1-2-5-12(15-6-3-4-9-18-15)11-7-8-13(16)14(17)10-11/h7-8,10,12,15,18H,2-6,9H2,1H3
Standard InChI Key: USGRALLMTYXJMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
13.6827 -25.4580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8197 -25.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5375 -25.4692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2525 -25.8829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9699 -25.4729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9715 -24.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2499 -24.2277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5354 -24.6442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1078 -25.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1114 -24.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4035 -24.2274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6869 -24.6337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3951 -25.8761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8170 -26.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6816 -25.8869 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.1025 -27.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3907 -26.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6850 -24.2335 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
5 6 2 0
3 4 2 0
6 7 1 0
9 13 1 0
10 11 1 0
11 12 1 0
12 1 1 0
1 13 1 0
2 3 1 0
2 14 1 0
7 8 2 0
5 15 1 0
8 3 1 0
14 16 1 0
4 5 1 0
16 17 1 0
2 9 1 0
6 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.25 | Molecular Weight (Monoisotopic): 285.1051 | AlogP: 5.02 | #Rotatable Bonds: 4 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 10.22 | CX LogP: 5.19 | CX LogD: 2.51 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.82 | Np Likeness Score: -0.08 |
References
1. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |
2. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |